BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22410782)

  • 1. Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane.
    Chiu CF; Ho MY; Peng JM; Hung SW; Lee WH; Liang CM; Liang SM
    Oncogene; 2013 Feb; 32(6):777-87. PubMed ID: 22410782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant viral capsid protein VP1 suppresses migration and invasion of human cervical cancer by modulating phosphorylated prohibitin in lipid rafts.
    Chiu CF; Peng JM; Hung SW; Liang CM; Liang SM
    Cancer Lett; 2012 Jul; 320(2):205-14. PubMed ID: 22388104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling.
    Fang CH; Lin YT; Liang CM; Liang SM
    J Biomed Sci; 2020 Mar; 27(1):42. PubMed ID: 32169072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of lipid raft translocation of prohibitin in regulation of Akt and Raf-protected apoptosis of HaCaT cells upon ultraviolet B irradiation.
    Wu Q; Wu S
    Mol Carcinog; 2017 Jul; 56(7):1789-1797. PubMed ID: 28218425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced increase in cell migration and metastatic potential of cervical cancer cells operates via the K-Ras pathway.
    Su WH; Chuang PC; Huang EY; Yang KD
    Am J Pathol; 2012 Feb; 180(2):862-71. PubMed ID: 22138581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS; Schäfer R; Der CJ
    Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis.
    Ho MY; Liang CM; Liang SM
    Oncotarget; 2015 Jan; 6(1):381-93. PubMed ID: 25575814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma.
    Luan Z; He Y; Alattar M; Chen Z; He F
    Mol Cancer; 2014 Feb; 13():38. PubMed ID: 24568222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation.
    Mason CS; Springer CJ; Cooper RG; Superti-Furga G; Marshall CJ; Marais R
    EMBO J; 1999 Apr; 18(8):2137-48. PubMed ID: 10205168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling.
    Ande SR; Mishra S
    Biochem Biophys Res Commun; 2009 Dec; 390(3):1023-8. PubMed ID: 19854158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
    Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis.
    Pap T; Nawrath M; Heinrich J; Bosse M; Baier A; Hummel KM; Petrow P; Kuchen S; Michel BA; Gay RE; Müller-Ladner U; Moelling K; Gay S
    Arthritis Rheum; 2004 Sep; 50(9):2794-802. PubMed ID: 15457447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prohibitin in cell signaling.
    Mishra S; Ande SR; Nyomba BL
    FEBS J; 2010 Oct; 277(19):3937-46. PubMed ID: 20840588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras-Raf signaling needs prohibitin.
    Rajalingam K; Rudel T
    Cell Cycle; 2005 Nov; 4(11):1503-5. PubMed ID: 16294014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways.
    Agarwal S; Corbley MJ; Roberts TM
    Oncogene; 1995 Aug; 11(3):427-38. PubMed ID: 7543194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
    Céspedes MV; Sancho FJ; Guerrero S; Parreño M; Casanova I; Pavón MA; Marcuello E; Trias M; Cascante M; Capellà G; Mangues R
    Carcinogenesis; 2006 Nov; 27(11):2190-200. PubMed ID: 16679305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.